Published May 30, 2022
| Version v1
Journal article
Open
Clostridioides (Clostridium) difficile infection: Review of literature
Authors/Creators
- 1. PGY2, Department of Internal Medicine Sunrise Health GME Consortium 2880 N Tenaya Way 2nd Floor Las Vegas, NV, USA.
- 2. PGY3, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA 3PGY1, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
- 3. PGY1, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
- 4. Mountain View Medical Center.
- 5. HCA Healthcare, Nashville TN.
- 6. Faculty Attending, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
Description
Clostridioides (Clostridium) difficile (C. difficile) is a gram-positive bacterium that infects the large intestine. The number of clostridium difficile infections has increased in the recent years due to multiple risk factors including frequent use of antibiotics and proton pump inhibitors. The virulence of C. difficile comes from its production of toxins. Treatment for C. difficile infection includes the use of antibiotics, monoclonal antibodies, or a fecal transplant.